Expanding on the phenotypic spectrum of Woodhouse‐Sakati syndrome due to founder pathogenic variant in <i>DCAF17</i>: Report of 58 additional patients from Qatar and literature review

<p dir="ltr">Woodhouse-Sakati syndrome (WSS) is a rare autosomal recessive neuroendocrine and ectodermal disorder caused by variants in the <i>DCAF17</i> gene. In Qatar, the c.436delC variant has been reported as a possible founder pathogenic variant with striking phenoty...

Full description

Saved in:
Bibliographic Details
Main Author: Rehab Ali (14152668) (author)
Other Authors: Nader Al‐Dewik (14777014) (author), Shayma Mohammed (13020777) (author), Mahmud Elfituri (14777017) (author), Sahar Agouba (14777020) (author), Sara Musa (14152662) (author), Laila Mahmoud (14777023) (author), Mariam Almulla (14152656) (author), Karen El‐Akouri (14776951) (author), Howaida Mohd (14777026) (author), Reem Bux (14777029) (author), Hajer Almulla (14152650) (author), Amna Othman (14152659) (author), Fatma Al‐Mesaifri (14776963) (author), Noora Shahbeck (14152671) (author), Mariam Al‐Muriekhi (14777032) (author), Amal Khalifa (14777035) (author), Reem Al‐Sulaiman (14776948) (author), Tawfeg Ben‐Omran (14776975) (author)
Published: 2021
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513555857932288
author Rehab Ali (14152668)
author2 Nader Al‐Dewik (14777014)
Shayma Mohammed (13020777)
Mahmud Elfituri (14777017)
Sahar Agouba (14777020)
Sara Musa (14152662)
Laila Mahmoud (14777023)
Mariam Almulla (14152656)
Karen El‐Akouri (14776951)
Howaida Mohd (14777026)
Reem Bux (14777029)
Hajer Almulla (14152650)
Amna Othman (14152659)
Fatma Al‐Mesaifri (14776963)
Noora Shahbeck (14152671)
Mariam Al‐Muriekhi (14777032)
Amal Khalifa (14777035)
Reem Al‐Sulaiman (14776948)
Tawfeg Ben‐Omran (14776975)
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author_facet Rehab Ali (14152668)
Nader Al‐Dewik (14777014)
Shayma Mohammed (13020777)
Mahmud Elfituri (14777017)
Sahar Agouba (14777020)
Sara Musa (14152662)
Laila Mahmoud (14777023)
Mariam Almulla (14152656)
Karen El‐Akouri (14776951)
Howaida Mohd (14777026)
Reem Bux (14777029)
Hajer Almulla (14152650)
Amna Othman (14152659)
Fatma Al‐Mesaifri (14776963)
Noora Shahbeck (14152671)
Mariam Al‐Muriekhi (14777032)
Amal Khalifa (14777035)
Reem Al‐Sulaiman (14776948)
Tawfeg Ben‐Omran (14776975)
author_role author
dc.creator.none.fl_str_mv Rehab Ali (14152668)
Nader Al‐Dewik (14777014)
Shayma Mohammed (13020777)
Mahmud Elfituri (14777017)
Sahar Agouba (14777020)
Sara Musa (14152662)
Laila Mahmoud (14777023)
Mariam Almulla (14152656)
Karen El‐Akouri (14776951)
Howaida Mohd (14777026)
Reem Bux (14777029)
Hajer Almulla (14152650)
Amna Othman (14152659)
Fatma Al‐Mesaifri (14776963)
Noora Shahbeck (14152671)
Mariam Al‐Muriekhi (14777032)
Amal Khalifa (14777035)
Reem Al‐Sulaiman (14776948)
Tawfeg Ben‐Omran (14776975)
dc.date.none.fl_str_mv 2021-09-30T06:00:00Z
dc.identifier.none.fl_str_mv 10.1002/ajmg.a.62501
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Expanding_on_the_phenotypic_spectrum_of__Woodhouse_Sakati__syndrome_due_to_founder_pathogenic_variant_in____i_DCAF17_i____Report_of_58_additional_patients_from_Qatar_and_literature_review/22257502
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biological sciences
Genetics
Biomedical and clinical sciences
Clinical sciences
c.436delC
DCAF17 gene
founder pathogenic variant
Qatar
variable clinical manifestations
Woodhouse-Sakati syndrome
dc.title.none.fl_str_mv Expanding on the phenotypic spectrum of Woodhouse‐Sakati syndrome due to founder pathogenic variant in <i>DCAF17</i>: Report of 58 additional patients from Qatar and literature review
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <p dir="ltr">Woodhouse-Sakati syndrome (WSS) is a rare autosomal recessive neuroendocrine and ectodermal disorder caused by variants in the <i>DCAF17</i> gene. In Qatar, the c.436delC variant has been reported as a possible founder pathogenic variant with striking phenotypic heterogeneity. In this retrospective study, we report on the clinical and molecular characteristics of additional 58 additional Qatari patients with WSS and compare them to international counterparts' findings. A total of 58 patients with WSS from 32 consanguineous families were identified. Ectodermal and endocrine (primary hypogonadism) manifestations were the most common presentations (100%), followed by diabetes mellitus (46%) and hypothyroidism (36%). Neurological manifestations were overlapping among patients with intellectual disability (ID) being the most common (75%), followed by sensorineural hearing loss (43%) and both ID and aggressive behavior (10%). Distinctive facial features were noted in all patients and extrapyramidal manifestations were uncommon (8.6%). This study is the largest to date on Qatari patients with WSS and highlights the high incidence and clinical heterogeneity of WSS in Qatar due to a founder variant c.436delC in the <i>DCAF17</i> gene. Early suspicion of WSS among Qatari patients with hypogonadism and ID, even in the absence of other manifestations, would shorten the diagnostic odyssey, guide early and appropriate management, and avoid potential complications.</p><h2>Other Information</h2><p dir="ltr">Published in: American Journal of Medical Genetics Part A<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="http://dx.doi.org/10.1002/ajmg.a.62501" target="_blank">http://dx.doi.org/10.1002/ajmg.a.62501</a></p><p dir="ltr">Additional institutions affiliated with: National Center for Rare Disease - HMC</p>
eu_rights_str_mv openAccess
id Manara2_2451f6504c4ea843276d1ec2d9b6c1d2
identifier_str_mv 10.1002/ajmg.a.62501
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/22257502
publishDate 2021
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Expanding on the phenotypic spectrum of Woodhouse‐Sakati syndrome due to founder pathogenic variant in <i>DCAF17</i>: Report of 58 additional patients from Qatar and literature reviewRehab Ali (14152668)Nader Al‐Dewik (14777014)Shayma Mohammed (13020777)Mahmud Elfituri (14777017)Sahar Agouba (14777020)Sara Musa (14152662)Laila Mahmoud (14777023)Mariam Almulla (14152656)Karen El‐Akouri (14776951)Howaida Mohd (14777026)Reem Bux (14777029)Hajer Almulla (14152650)Amna Othman (14152659)Fatma Al‐Mesaifri (14776963)Noora Shahbeck (14152671)Mariam Al‐Muriekhi (14777032)Amal Khalifa (14777035)Reem Al‐Sulaiman (14776948)Tawfeg Ben‐Omran (14776975)Biological sciencesGeneticsBiomedical and clinical sciencesClinical sciencesc.436delCDCAF17 genefounder pathogenic variantQatarvariable clinical manifestationsWoodhouse-Sakati syndrome<p dir="ltr">Woodhouse-Sakati syndrome (WSS) is a rare autosomal recessive neuroendocrine and ectodermal disorder caused by variants in the <i>DCAF17</i> gene. In Qatar, the c.436delC variant has been reported as a possible founder pathogenic variant with striking phenotypic heterogeneity. In this retrospective study, we report on the clinical and molecular characteristics of additional 58 additional Qatari patients with WSS and compare them to international counterparts' findings. A total of 58 patients with WSS from 32 consanguineous families were identified. Ectodermal and endocrine (primary hypogonadism) manifestations were the most common presentations (100%), followed by diabetes mellitus (46%) and hypothyroidism (36%). Neurological manifestations were overlapping among patients with intellectual disability (ID) being the most common (75%), followed by sensorineural hearing loss (43%) and both ID and aggressive behavior (10%). Distinctive facial features were noted in all patients and extrapyramidal manifestations were uncommon (8.6%). This study is the largest to date on Qatari patients with WSS and highlights the high incidence and clinical heterogeneity of WSS in Qatar due to a founder variant c.436delC in the <i>DCAF17</i> gene. Early suspicion of WSS among Qatari patients with hypogonadism and ID, even in the absence of other manifestations, would shorten the diagnostic odyssey, guide early and appropriate management, and avoid potential complications.</p><h2>Other Information</h2><p dir="ltr">Published in: American Journal of Medical Genetics Part A<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="http://dx.doi.org/10.1002/ajmg.a.62501" target="_blank">http://dx.doi.org/10.1002/ajmg.a.62501</a></p><p dir="ltr">Additional institutions affiliated with: National Center for Rare Disease - HMC</p>2021-09-30T06:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1002/ajmg.a.62501https://figshare.com/articles/journal_contribution/Expanding_on_the_phenotypic_spectrum_of__Woodhouse_Sakati__syndrome_due_to_founder_pathogenic_variant_in____i_DCAF17_i____Report_of_58_additional_patients_from_Qatar_and_literature_review/22257502CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/222575022021-09-30T06:00:00Z
spellingShingle Expanding on the phenotypic spectrum of Woodhouse‐Sakati syndrome due to founder pathogenic variant in <i>DCAF17</i>: Report of 58 additional patients from Qatar and literature review
Rehab Ali (14152668)
Biological sciences
Genetics
Biomedical and clinical sciences
Clinical sciences
c.436delC
DCAF17 gene
founder pathogenic variant
Qatar
variable clinical manifestations
Woodhouse-Sakati syndrome
status_str publishedVersion
title Expanding on the phenotypic spectrum of Woodhouse‐Sakati syndrome due to founder pathogenic variant in <i>DCAF17</i>: Report of 58 additional patients from Qatar and literature review
title_full Expanding on the phenotypic spectrum of Woodhouse‐Sakati syndrome due to founder pathogenic variant in <i>DCAF17</i>: Report of 58 additional patients from Qatar and literature review
title_fullStr Expanding on the phenotypic spectrum of Woodhouse‐Sakati syndrome due to founder pathogenic variant in <i>DCAF17</i>: Report of 58 additional patients from Qatar and literature review
title_full_unstemmed Expanding on the phenotypic spectrum of Woodhouse‐Sakati syndrome due to founder pathogenic variant in <i>DCAF17</i>: Report of 58 additional patients from Qatar and literature review
title_short Expanding on the phenotypic spectrum of Woodhouse‐Sakati syndrome due to founder pathogenic variant in <i>DCAF17</i>: Report of 58 additional patients from Qatar and literature review
title_sort Expanding on the phenotypic spectrum of Woodhouse‐Sakati syndrome due to founder pathogenic variant in <i>DCAF17</i>: Report of 58 additional patients from Qatar and literature review
topic Biological sciences
Genetics
Biomedical and clinical sciences
Clinical sciences
c.436delC
DCAF17 gene
founder pathogenic variant
Qatar
variable clinical manifestations
Woodhouse-Sakati syndrome